Across TCGA pan-cancer cohorts, KIAA0087 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated KIAA0087 data layer compared with 3 for mass-spec protein.
The strongest signal is observed in esophageal carcinoma (ESCA), where higher KIAA0087 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated KIAA0087 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUAD show a favorable association.
ESCA, THCA, and UVM are the cancer types where KIAA0087 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.